https://www.taxtmi.com/news?id=24968 Approval under Section 31(1) of the Competition Act, 2002 was granted for the two GlaxoSmithKline consumer healthcare subsidiaries to acquire 100% of the share capital of GlaxoSmithKline Asia Private Limited, and precedes the transfer of India trademarks for the "Iodex" and "Ostocalcium" brands and associated legal, economic, commercial and marketing rights from GlaxoSmithKline Pharmaceuticals Limited to GSKAPL. en-us Mon, 24 Jan 2022 11:22:29 +0530 Mon, 24 Jan 2022 11:22:29 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=24968 Approval under Section 31(1) of the Competition Act, 2002 was granted for the two GlaxoSmithKline consumer healthcare subsidiaries to acquire 100% of the share capital of GlaxoSmithKline Asia Private Limited, and precedes the transfer of India trademarks for the "Iodex" and "Ostocalcium" brands and associated legal, economic, commercial and marketing rights from GlaxoSmithKline Pharmaceuticals Limited to GSKAPL. News - Mon, 24 Jan 2022 11:22:29 +0530 https://www.taxtmi.com/news?id=24968